Task: Answer the multiple choice question.
Question: Which drug exhibits a 12.622% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a. CNC(=O)c1cc2c(ccc3ccccc32)oc1=N
b. Cc1c(C(=O)N2CCCCCC2)c(S(=O)(=O)Nc2ccc(F)cc2)c(C)n1C
c. CCCn1c(NCc2ccc3c(c2)OCO3)nc2ccccc21
d. Cc1ccc(-c2nc(=S)c3c(n2Cc2cccnc2)CC(C)(C)OC3)cc1
Answer: c. CCCn1c(NCc2ccc3c(c2)OCO3)nc2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCn1c(NCc2ccc3c(c2)OCO3)nc2ccccc21
CCCn1c(NCc2ccc3c(c2)OCO3)nc2ccccc21
N-(1,3-benzodioxol-5-ylmethyl)-1-propylbenzimidazol-2-amine